International Immunopharmacology, Journal Year: 2024, Volume and Issue: 145, P. 113711 - 113711
Published: Dec. 7, 2024
Language: Английский
International Immunopharmacology, Journal Year: 2024, Volume and Issue: 145, P. 113711 - 113711
Published: Dec. 7, 2024
Language: Английский
Journal of Alzheimer s Disease, Journal Year: 2025, Volume and Issue: unknown
Published: March 20, 2025
Background Alzheimer's disease (AD) is a chronic brain degenerative that leads to dementia. Objective The aim of the present study investigate neuroprotective impact sodium-glucose cotransporter-2 inhibitors (SGLT2i) (empagliflozin and dapagliflozin) on tau phosphorylation, oxidative stress, neuroinflammation. Methods We used MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) assay, annexin-V-FITC kit, DCFH-DA (dichloro-dihydro-fluorescein diacetate) respectively evaluate effect SGLT2i amyloid-β (Aβ) 1–42 -induced neuronal death, apoptosis, stress. expression NLRP3-inflammasome, phospho-Tau181, glycogen synthase kinase-3 beta (GSK-3β), cyclin-dependent kinase 5 (CdK5), histone deacetylase 6 (HDAC6), was quantified by flow cytometry. Drug distribution in mice's brains assessed liquid chromatography-mass spectrometry (LC-MS). Results Aβ significantly reduced cell viability increased which reversed using gliflozins. reactive oxygen species generation, downregulated diminished pathology. Mechanistically, last involved modulation GSK-3β CdK5 protein expression. However, tested treatments did not modify -stimulating HDAC6. Gliflozins are substrates drug transporters ATP-binding cassette sub-family B member 1 and/or ATP binding subfamily G 2 (ABCB1 ABCG2), Elacridar enhances their distribution. Conclusions empagliflozin dapagliflozin exhibited actions against human neurotoxicity.
Language: Английский
Citations
0Behavioural Brain Research, Journal Year: 2025, Volume and Issue: unknown, P. 115545 - 115545
Published: March 1, 2025
Language: Английский
Citations
0Cells, Journal Year: 2025, Volume and Issue: 14(7), P. 507 - 507
Published: March 29, 2025
Empagliflozin (EMPA), a sodium-glucose co-transporter 2 (SGLT2) inhibitor, prevents endothelial dysfunction, but its effects on vascular tone in hypertension remain unclear. This study investigated whether EMPA modulates vasomotor via sirtuin 1 (SIRT1) and AMP-activated protein kinase (AMPK) pathways spontaneously hypertensive rats (SHR) controls (Wistar Kyoto rats, WKY). Functional (wire myography, organ bath) biochemical (Western blot) studies were conducted the third-order of superior mesenteric arteries (sMAs) and/or aortas. induced concentration-dependent relaxation preconstricted sMAs both groups. In SHR, enhanced acetylcholine (Ach)-induced aortas reduced constriction by phenylephrine (Phe) U46619 sMAs. The SIRT1 inhibitor (EX527) abolished EMPA’s Ach-mediated U46619-induced vasoconstriction, while AMPK inhibition Phe-induced vasoconstriction. SHR showed increased SGLT2 expression decreased pAMPK/AMPK levels conclusion, might exert vasoprotective enhancing endothelium-dependent reducing AMPK/SIRT1 pathways. These properties could improve health patients with related conditions. Further are needed to explore new indications for inhibitors.
Language: Английский
Citations
0Cells, Journal Year: 2024, Volume and Issue: 13(22), P. 1876 - 1876
Published: Nov. 13, 2024
Glucose metabolism is essential for the maintenance and function of central nervous system. Although brain constitutes only 2% body weight, it consumes approximately 20% body’s total energy, predominantly derived from glucose. This high energy demand underscores its reliance on glucose to fuel various functions, including neuronal activity, synaptic transmission, ion gradients necessary nerve impulse transmission. Increasing evidence shows that many neurodegenerative diseases, Parkinson’s disease (PD), are associated with abnormalities in metabolism. PD characterized by progressive loss dopaminergic neurons substantia nigra, accompanied accumulation α-synuclein protein aggregates. These pathological features exacerbated mitochondrial dysfunction, oxidative stress, neuroinflammation, all which influenced disruptions. Emerging suggests targeting could offer therapeutic benefits PD. Several antidiabetic drugs have shown promise animal models clinical trials mitigating symptoms progression review explores current understanding association between metabolism, emphasizing potential medications as a novel approach. By improving uptake utilization, enhancing function, reducing these address key pathophysiological mechanisms PD, offering hope more effective management this debilitating disease.
Language: Английский
Citations
2Published: July 25, 2024
3.9 million individuals rely on kidney replacement therapy worldwide. They experience height-ened susceptibility to cardiovascular diseases and mortality, alongside an increased risk of in-fections malignancies, with inflammation being key explaining this intensified risk. This study utilized semi-targeted metabolomics explore novel metabolic pathways related in-flammation in populations. We collected pre post-session blood samples patients who had already undergone one year chronic hemodialysis. And used liquid chromatography high resolution mass spectrometry perform a metabolomic analysis. Afterwards, we employed both univariate (Mann-Whitney test) multivariate (logistic regression LASSO regulari-zation) identify metabolites associated inflammation. In the analysis, in-dole-3-acetaldehyde, 2-ketobutyric acid, urocanic acid showed statistically significant de-creases median concentrations presence positively include allantoin, taurodeoxycholic norepinephrine, pyroglutamic L-hydroorotic acid. Conversely, showing negative associations benzoic indole-3-acetaldehyde, methio-nine, citrulline, alphaketoglutarate, n-acetyl-ornithine 3-4-dihydroxibenzeneacetic Non inflamed exhibit preserved autophagy reduced mitochondrial dysfunction. Under-standing group hinges metabolism arginine urea cycle. Additionally, microbiota, particularly uricase-producing bacteria those metabolizing tryptophan, play critical roles.
Language: Английский
Citations
1Journal of Biochemical and Molecular Toxicology, Journal Year: 2024, Volume and Issue: 38(12)
Published: Dec. 1, 2024
ABSTRACT One of the key challenges in medical research is developing safe medications to treat neurodegenerative disorders. Increased oxidative stress, mitochondrial dysfunction, and neuroinflammation are common features Alzheimer's disease (AD) Parkinson's (PD). Silent information regulator 1 (SIRT‐1), part sirtuin family, plays a critical role various physiological processes by binding histones nonhistone proteins. SIRT‐1 primarily mitigates stress regulates activity maintaining deacetylated form peroxisome proliferator‐activated receptor‐γ coactivator‐1α (PGC‐1α), ensuring stable PGC‐1α levels. Research has shown reduced SIRT‐1/PGC‐1α expression AD PD models. Targeting this pathway presents promising therapeutic approach for managing PD, potentially leading disease‐modifying treatments improved outcomes. This review highlights findings studies suggesting that promotes biogenesis, synaptic plasticity, cognitive function, as well exerts antioxidant, anti‐inflammatory, anti‐apoptotic effects, offering potential method treatment.
Language: Английский
Citations
1International Immunopharmacology, Journal Year: 2024, Volume and Issue: 146, P. 113839 - 113839
Published: Dec. 18, 2024
Language: Английский
Citations
1International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(17), P. 9364 - 9364
Published: Aug. 29, 2024
Worldwide, 3.9 million individuals rely on kidney replacement therapy. They experience heightened susceptibility to cardiovascular diseases and mortality, alongside an increased risk of infections malignancies, with inflammation being key explaining this intensified risk. This study utilized semi-targeted metabolomics explore novel metabolic pathways related in population. We collected pre- post-session blood samples patients who had already undergone one year chronic hemodialysis used liquid chromatography high-resolution mass spectrometry perform a metabolomic analysis. Afterwards, we employed both univariate (Mann–Whitney test) multivariate (logistic regression LASSO regularization) identify metabolites associated inflammation. In the analysis, indole-3-acetaldehyde, 2-ketobutyric acid, urocanic acid showed statistically significant decreases median concentrations presence positively included allantoin, taurodeoxycholic norepinephrine, pyroglutamic L-hydroorotic acid. Conversely, showing negative associations benzoic methionine, citrulline, alphaketoglutarate, n-acetyl-ornithine, 3-4-dihydroxibenzeneacetic Non-inflamed exhibit preserved autophagy reduced mitochondrial dysfunction. Understanding group hinges metabolism arginine urea cycle. Additionally, microbiota, particularly uricase-producing bacteria those metabolizing tryptophan, play critical roles.
Language: Английский
Citations
0NeuroToxicology, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 1, 2024
Language: Английский
Citations
0International Immunopharmacology, Journal Year: 2024, Volume and Issue: 145, P. 113711 - 113711
Published: Dec. 7, 2024
Language: Английский
Citations
0